Bank of New York Mellon’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.74M | Sell |
201,151
-13,080
| -6% | -$568K | ﹤0.01% | 1963 |
|
|
2025
Q1 | $8M | Buy |
214,231
+103,404
| +93% | +$3.86M | ﹤0.01% | 1962 |
|
|
2024
Q4 | $5.02M | Sell |
110,827
-1,774
| -2% | -$80.4K | ﹤0.01% | 2286 |
|
|
2024
Q3 | $6.61M | Sell |
112,601
-23,146
| -17% | -$1.36M | ﹤0.01% | 2146 |
|
|
2024
Q2 | $5.34M | Sell |
135,747
-1,520
| -1% | -$59.8K | ﹤0.01% | 2312 |
|
|
2024
Q1 | $9.12M | Buy |
137,267
+71,584
| +109% | +$4.76M | ﹤0.01% | 2004 |
|
|
2023
Q4 | $1.84M | Buy |
65,683
+6,023
| +10% | +$168K | ﹤0.01% | 2873 |
|
|
2023
Q3 | $1.27M | Buy |
+59,660
| New | +$1.27M | ﹤0.01% | 3031 |
|